{"DataElement":{"publicId":"3838317","version":"1","preferredName":"Chronic Myelogenous Leukemia Phase Status Diseases and Disorders Count","preferredDefinition":"The total number of chronic myelogenous leukemia disease phases.","longName":"3838316v1.0:2675117v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3838316","version":"1","preferredName":"Chronic Myelogenous Leukemia Phase Status","preferredDefinition":"A chronic myeloproliferative neoplasm characterized by the expression of the BCR-ABL1 fusion gene. It presents with neutrophilic leukocytosis. It can appear at any age, but it mostly affects middle aged and older individuals. Patients usually present with fatigue, weight loss, anemia, night sweats, and splenomegaly. If untreated, it follows a biphasic or triphasic natural course; an initial indolent chronic phase which is followed by an accelerated phase, a blast phase, or both. Allogeneic stem cell transplantation and tyrosine kinase inhibitors delay disease progression and prolong overall survival._A distinguishable part, a stage in a series of events or in a process of development, e.g. any of the varying aspects or stages in course of a disease; a fraction of a cycle._A condition or state at a particular time.","longName":"2500393v1.0:2320064v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2500393","version":"1","preferredName":"CML","preferredDefinition":"The most common chronic myeloproliferative disorder characterized by neutrophilic leukocytosis.  It is associated with the Philadelphia (Ph) chromosome and/or the BCR/ABL fusion gene.  Most patients are middle-aged or elderly.  Common findings at presentation include fatigue, weight loss, anemia, night sweats, and splenomegaly.  The disease is bi- or triphasic: an initial indolent chronic phase is followed by accelerated or blast phase.  Allogeneic bone marrow transplantation is currently the only curative therapy (adapted from WHO 2001).  -- 2003","longName":"C3174","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Myeloid Leukemia, BCR-ABL1 Positive","conceptCode":"C3174","definition":"A chronic myeloproliferative neoplasm characterized by the expression of the BCR-ABL1 fusion gene. It presents with neutrophilic leukocytosis. It can appear at any age, but it mostly affects middle aged and older individuals. Patients usually present with fatigue, weight loss, anemia, night sweats, and splenomegaly. If untreated, it follows a biphasic or triphasic natural course; an initial indolent chronic phase which is followed by an accelerated phase, a blast phase, or both. Allogeneic stem cell transplantation and tyrosine kinase inhibitors delay disease progression and prolong overall survival.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1995DB3E-65B1-6546-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-27","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-27","modifiedBy":"ONEDATA","dateModified":"2006-07-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3946431","version":"1","preferredName":"Phase Status","preferredDefinition":"Phase; any distinct time period in a sequence of events:A condition or state at a particular time.","longName":"C25257:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phase","conceptCode":"C25257","definition":"A distinguishable part, a stage in a series of events or in a process of development, e.g. any of the varying aspects or stages in course of a disease; a fraction of a cycle.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EA85A00C-116B-A9B5-E040-BB89AD43351F","latestVersionIndicator":"Yes","beginDate":"2013-11-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-06","modifiedBy":"ONEDATA","dateModified":"2013-11-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E347E9A9-B691-819B-E040-BB89AD4313AE","latestVersionIndicator":"Yes","beginDate":"2013-08-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-08-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":". Updated def for CML. No version needed. AK 11/3/14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2675117","version":"1.1","preferredName":"Diseases and Disorders Status Count","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown._A condition or state at a particular time._To determine the number or amount of something; the result of this activity.","longName":"DS_ST_CT","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"3rd or higher","valueDescription":"Greater Third","ValueMeaning":{"publicId":"2675118","version":"1","preferredName":"Greater Third","longName":"2675118","preferredDefinition":"Notable in size, number, measure, magnitude, degree, or effectiveness.: Following the second position in an ordering or series.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater","conceptCode":"C61421","definition":"Notable in size, number, measure, magnitude, degree, or effectiveness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Third","conceptCode":"C25260","definition":"Following the second position in an ordering or series; coming next after the second and just before the fourth in position.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"38DB1529-0D43-7114-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-29","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E993195B-16AE-F26B-E040-BB89AD43787C","beginDate":"2007-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-25","modifiedBy":"ONEDATA","dateModified":"2013-10-25","deletedIndicator":"No"},{"value":"1st","valueDescription":"First","ValueMeaning":{"publicId":"2578677","version":"1","preferredName":"First","longName":"2578677","preferredDefinition":"Preceding all others in time or space or degree.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0062-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-17","endDate":null,"createdBy":"HARDINGR","dateCreated":"2006-04-17","modifiedBy":"KUMMEROA","dateModified":"2023-08-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E993195B-1686-F26B-E040-BB89AD43787C","beginDate":"2007-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-25","modifiedBy":"ONEDATA","dateModified":"2013-10-25","deletedIndicator":"No"},{"value":"2nd","valueDescription":"Second:C25666","ValueMeaning":{"publicId":"2672762","version":"1","preferredName":"Second:C25666","longName":"2672762","preferredDefinition":"Coming next after the first in position in space or time or degree or magnitude.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Second","conceptCode":"C25666","definition":"Coming next after the first in position in space or time or degree or magnitude.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"37C86417-4F58-0BF6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-15","endDate":null,"createdBy":"DWARZEL","dateCreated":"2007-08-15","modifiedBy":"DWARZEL","dateModified":"2022-10-03","changeDescription":"Updated VM Short Name to be the Public ID to be consistent with current convention for VM Short Name - DW 10-03-2022","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E993195B-169A-F26B-E040-BB89AD43787C","beginDate":"2007-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-25","modifiedBy":"ONEDATA","dateModified":"2013-10-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2677056","version":"1","preferredName":"Diseases and Disorders Status Count","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.:A condition or state at a particular time.:To determine the number or amount of something; the result of this activity.","longName":"C2991:C25688:C25463","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Count","conceptCode":"C25463","definition":"Determining the number or amount of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3962D0C2-10AC-058E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-05","modifiedBy":"ONEDATA","dateModified":"2007-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E993195B-161D-F26B-E040-BB89AD43787C","latestVersionIndicator":"Yes","beginDate":"2013-10-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-25","modifiedBy":"KUMMEROA","dateModified":"2014-01-08","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"PreTed_prime_dis_hct_cml_remiss_count","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedMedicalConditionResult:value","type":"HCT_BRIDG","context":"NHLBI"},{"name":"TDIS_CML_remiss_count","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What were the number of the C","type":"Preferred Question Text","description":"What were the number of the CML phase status?","url":null,"context":"NHLBI"},{"name":"Number","type":"Alternate Question Text","description":"Number","url":null,"context":"NHLBI"},{"name":"Number","type":"Application Standard Question Text","description":"Number","url":null,"context":"NHLBI"},{"name":"BRIDG Mapping for CDE:3838317","type":"BRIDG Mapping Path","description":"\"PerformedMedicalConditionResult.value WHERE PerformedMedicalConditionResult > PerformedObservation > DefinedObservation.nameCode = \"\"assess diagnosis\"\"  AND PerformedObservation > AssessedResultRelationship > PerformedDiagnosis.value = \"\"Chronic Myelogenous Leukemia(CML)\"\" AND PerformedObservation.dateRange IS EQUAL TO {transplant date}  {transplant date} is determiend by: PerformedDiagnosis > PerformedSubstanceAdministration.dateRange WHERE PerformedSubstanceAdministration > DefinedSubstranceAdministration.nameCode = \"\"Administer Hematopoietic Cell Product{ Transplantation}\"\"\"","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E347E9A9-B6A4-819B-E040-BB89AD4313AE","latestVersionIndicator":"Yes","beginDate":"2013-08-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-08-06","modifiedBy":"ALEYR","dateModified":"2019-04-13","changeDescription":".1/15/14mn-added BRIDG info. Added human readable def. System generated def displayed as alt def. No version needed. AK 11/3/14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}